1.37
price down icon1.44%   -0.02
after-market Dopo l'orario di chiusura: 1.32 -0.05 -3.65%
loading
Precedente Chiudi:
$1.39
Aprire:
$1.4
Volume 24 ore:
338.71K
Relative Volume:
0.66
Capitalizzazione di mercato:
$61.48M
Reddito:
$19.94M
Utile/perdita netta:
$-37.37M
Rapporto P/E:
-1.3173
EPS:
-1.04
Flusso di cassa netto:
$-33.38M
1 W Prestazione:
-2.14%
1M Prestazione:
+9.60%
6M Prestazione:
-0.72%
1 anno Prestazione:
-50.18%
Intervallo 1D:
Value
$1.25
$1.43
Intervallo di 1 settimana:
Value
$1.25
$1.485
Portata 52W:
Value
$0.595
$4.18

Werewolf Therapeutics Inc Stock (HOWL) Company Profile

Name
Nome
Werewolf Therapeutics Inc
Name
Telefono
617-952-0555
Name
Indirizzo
200 TALCOTT AVENUE, WATERTOWN
Name
Dipendente
46
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
HOWL's Discussions on Twitter

Confronta HOWL con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
HOWL
Werewolf Therapeutics Inc
1.37 62.82M 19.94M -37.37M -33.38M -1.04
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-04-03 Iniziato JMP Securities Mkt Outperform
2023-08-24 Iniziato Wedbush Outperform
2023-06-06 Ripresa Jefferies Buy
2021-09-10 Iniziato BofA Securities Buy
2021-05-25 Iniziato Evercore ISI Outperform
2021-05-25 Iniziato H.C. Wainwright Buy
2021-05-25 Iniziato Jefferies Buy
2021-05-25 Iniziato SVB Leerink Outperform
Mostra tutto

Werewolf Therapeutics Inc Borsa (HOWL) Ultime notizie

pulisher
Jul 24, 2025

Is Werewolf Therapeutics Inc. stock a growth or value playRecord-setting profit potential - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

What drives Werewolf Therapeutics Inc. stock priceSky-high return potential - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is Werewolf Therapeutics Inc. a good long term investmentRapidly growing investment returns - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Werewolf Therapeutics Inc. Stock Analysis and ForecastSuperior stock selection - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Werewolf Therapeutics Inc. stockHigh-velocity gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

How Werewolf Therapeutics Inc. stock performs during market volatilityFree Stock Trading Community - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Why Werewolf Therapeutics Inc. stock attracts strong analyst attentionHigh Potential Shares - Newser

Jul 22, 2025
pulisher
Jul 15, 2025

What makes Werewolf Therapeutics Inc. stock price move sharplyInvestor Favorite Picks - Newser

Jul 15, 2025
pulisher
Jul 10, 2025

Werewolf Therapeutics (HOWL) Upgraded to Buy: Here's What You Should Know - MSN

Jul 10, 2025
pulisher
Jul 10, 2025

Vontobel Holding Ltd. Acquires New Stake in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

Jul 10, 2025
pulisher
Jul 09, 2025

Werewolf Therapeutics to Present Innovative IL-2 INDUKINE Development at KidneyCAN 7th Annual Kidney Cancer Research Summit - Nasdaq

Jul 09, 2025
pulisher
Jul 09, 2025

Werewolf Therapeutics to Participate in the KidneyCAN 7th Annual Kidney Cancer Research Summit - GlobeNewswire

Jul 09, 2025
pulisher
Jul 07, 2025

Werewolf Therapeutics: A High-Risk, High-Potential Bet in Cancer Immunotherapy - criticalcontrolroomworld.com

Jul 07, 2025
pulisher
Jul 05, 2025

Werewolf Therapeutics (NASDAQ:HOWL) Trading Up 1% – What’s Next? - Defense World

Jul 05, 2025
pulisher
Jun 13, 2025

Werewolf Therapeutics Adopts New Bylaws and Elects Directors - TipRanks

Jun 13, 2025
pulisher
Jun 13, 2025

Two Sigma Investments LP Sells 87,168 Shares of Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Werewolf Therapeutics to Participate in the BIO International Convention - GlobeNewswire

Jun 12, 2025
pulisher
Jun 09, 2025

Jane Street Group LLC Acquires 39,564 Shares of Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

Two Sigma Advisers LP Sells 117,200 Shares of Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Shares Sold by Millennium Management LLC - Defense World

Jun 06, 2025
pulisher
Jun 03, 2025

Deutsche Bank AG Buys 83,172 Shares of Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

Jun 03, 2025
pulisher
Jun 01, 2025

Northern Trust Corp Acquires 16,640 Shares of Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

Jun 01, 2025
pulisher
Jun 01, 2025

Bank of America Corp DE Lowers Stock Position in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

Jun 01, 2025
pulisher
May 31, 2025

Werewolf Therapeutics Announces Q1 2025 Financial Results - MSN

May 31, 2025
pulisher
May 29, 2025

Werewolf Therapeutics Leaders to Reveal Latest Cancer Treatment Progress at Major Healthcare Conference - Stock Titan

May 29, 2025
pulisher
May 29, 2025

Werewolf Therapeutics to Participate in Fireside Chat at Jefferies Global Healthcare Conference on June 5, 2025 - Nasdaq

May 29, 2025

Werewolf Therapeutics Inc Azioni (HOWL) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):